Preclinical drug screening studies using organ-on-chip platforms

Background

Animal studies are resource consuming and ethically challenging to conduct for preclinical drug screening and testing. Therefore organ-on-chip systems are being developed for preclinical studies. These systems mimic in vivo organ physiology and function. High-throughput features can be implemented in these on-chip devices, and culture environments can be micro-manipulated in laboratories.

Learning Outcome (LO)

LO #1: Developing organ-on-chip models for drug testing by incorporating different biophysical features. Features of specific biomaterials used in developing chip devices. 

LO #2: Reviewing data on specific drug targets and comparing results using on-chip devices and other models.

What is on offer?

×